13
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Case study: Selective serotonin reuptake inhibitors in the treatment of severely disturbed preadolescents with comorbid diagnosis

Pages 431-433 | Published online: 12 Jul 2009

References

  • Emslie GJ, Rush J, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, et al. A double-blind, randomized, placebocon-trolled trial of fluoxetine in children and adolescents with de-pression. Arch Gen Psychiatry 1997;54:1031–7.
  • Green WH. Antidepressant drugs. In: Green WH, editor. Child and adolescent clinical psychopharmacology, 2nd ed. Baltimore: Williams & Wilkins; 1995. p. 121–86.
  • Hazell P, O'Connell D, Heathcote D, Robertson J, Henry D. Efficacy of tricyclic drugs in treating child and adolescent de-pression: a meta-analysis. Br Med J 1995;310:897–901.
  • Kutcher S. Practitioner review: the pharmacotherapy of adoles-cent depression. J Child Psychol Psychiatr 1997;38:755–67.
  • Labellarte MJ, Walkup JT, Riddle MA. The new antidepres-sants: selective reuptake inhibitors. Pediatr Clin North Am 1998;45:1137–56.
  • Riddle MA, Nelson JC, Kleinman CS, Rasmusson A, Leckman JF, King RA, et al. Sudden death in children receiving Nor-pramin: a review of three reported cases and commentary. J Am Acad Child Adolesc Psychiatry 1991;30:104–8.
  • Kutcher S. Child & adolescent psychopharmacology. Philadel-phia: W B Saunders; 1997.
  • Simeon J, DiNicola V, Ferguson HB, Copping W. Adolescent depression: a placebocontrolled fluoxetine treatment study and follow-up. Prog Neuropsychopharmacol Biol Psychiatry 1990;14:791–5.
  • Lepola U, Leinonen E, Koponen H. Citalopram in the treat-ment of early-onset panic disorder and school phobia. Pharma-copsychiatry 1996;29–32.
  • Lepola U, Leinonen E, Koponen H. Citalopram in anxiety disorder of childhood and adolescence [letter]. Eur Child Ado-lesc Psychiatry 1994;3:277–9.
  • Thomsen PH. Child and adolescent obessive-compulsive disor-der treated with citalopram: findings from an open trial of 23 cases. J Child Adolesc Psychopharmacol 1997;7:157–66.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.